(0:10): Climate Crisis: 4,000 Glaciers Could Vanish Annually by 2030s, Urgent Mitigation Needed
(2:48): Moderna's mNEXSPIKE Set for European Expansion Following EMA Endorsement
(4:43): FDA Approves ENHERTU Combo as Breakthrough First-Line Therapy for HER2-Positive Breast Cancer
(7:22): Anixa Biosciences Takes Helm of Breast Cancer Vaccine Trials, Eyes Phase 2 Expansion
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.